These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1358183)

  • 1. EEG-brain mapping. A method to optimize therapy in schizophrenics using absolute power and center frequency values.
    Schellenberg R; Schwarz A; Knorr W; Haufe C
    Schizophr Res; 1992 Oct; 8(1):21-9. PubMed ID: 1358183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative EEG and BPRS data following Haldol-Decanoate administration in schizophrenics.
    Schellenberg R; Milch W; Schwarz A; Schober F; Dimpfel W
    Int Clin Psychopharmacol; 1994; 9(1):17-24. PubMed ID: 7910833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative symptoms and EEG alpha activity in schizophrenic patients.
    Merrin EL; Floyd TC
    Schizophr Res; 1992 Oct; 8(1):11-20. PubMed ID: 1358182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Average reference EEG lateralization in schizophrenic patients.
    Merrin EL; Floyd TC
    J Neuropsychiatry Clin Neurosci; 1991; 3(3):307-14. PubMed ID: 1687964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topographical changes in alpha power in medicated and unmedicated schizophrenics during digits span reverse matching test.
    Nagase Y; Okubo Y; Matsuura M; Kojima T
    Biol Psychiatry; 1992 Nov; 32(10):870-9. PubMed ID: 1361364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment.
    Galderisi S; Mucci A; Mignone ML; Maj M; Kemali D
    Schizophr Res; 1991 Dec; 6(1):15-23. PubMed ID: 1786232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EEG performance spectral mapping during drug therapy in a patient with schizophrenic psychosis].
    Schellenberg R; Schwarz A; Knorr W; Schindler M
    Psychiatr Neurol Med Psychol (Leipz); 1990 Oct; 42(10):618-24. PubMed ID: 1981811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative EEG of elderly schizophrenic patients.
    Omori M; Koshino Y; Murata T; Murata I; Horie T; Isaki K
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):681-92. PubMed ID: 1362590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimensional complexity of EEG brain mechanisms in untreated schizophrenia.
    Koukkou M; Lehmann D; Wackermann J; Dvorak I; Henggeler B
    Biol Psychiatry; 1993 Mar; 33(6):397-407. PubMed ID: 8098223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EEG coherence during hemispheric activation in schizophrenics.
    Michelogiannis S; Paritsis N; Trikas P
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):31-4. PubMed ID: 1832303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EEG coherence in unmedicated schizophrenic patients: topographical study of predominantly never medicated cases.
    Nagase Y; Okubo Y; Matsuura M; Kojima T; Toru M
    Biol Psychiatry; 1992 Dec; 32(11):1028-34. PubMed ID: 1467383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
    Czobor P; Volavka J
    J Clin Psychopharmacol; 1993 Oct; 13(5):332-42. PubMed ID: 7693770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerized EEG in schizophrenic patients.
    Miyauchi T; Tanaka K; Hagimoto H; Miura T; Kishimoto H; Matsushita M
    Biol Psychiatry; 1990 Sep; 28(6):488-94. PubMed ID: 2223918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EEG mapping--a new way of monitoring in epilepsy.
    Logar C; Walzl B; Lechner H
    Eur Neurol; 1994; 34 Suppl 1():24-8. PubMed ID: 8001605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EEG- and EP-mapping--possible indicators for disturbed information processing in schizophrenia?
    Schellenberg R; Schwarz A
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jul; 17(4):595-607. PubMed ID: 8103234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A loading-dose strategy for converting from oral to depot haloperidol.
    Ereshefsky L; Toney G; Saklad SR; Anderson C; Seidel D
    Hosp Community Psychiatry; 1993 Dec; 44(12):1155-61. PubMed ID: 7907570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parameters.
    Gattaz WF; Mayer S; Ziegler P; Platz M; Gasser T
    Eur Arch Psychiatry Clin Neurosci; 1992; 241(6):328-32. PubMed ID: 1504108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.